The Motley Fool
08 Jun 2026, 02:28 UTC · 10h ago
3 Reasons to Buy Green Thumb Industries Like There's No Tomorrow
The Motley Fool
08 Jun 2026, 02:28 UTC · 10h ago
Story key points
5 claims · impact-rated
The U.S. Department of Justice rescheduled cannabis from Schedule I to Schedule III on April 23. — This is a fundamental regulatory shift that removes the 280E tax burden, allowing companies to deduct standard corporate expenses and significantly expand net margins.
+0.80The legal U.S. cannabis market is projected to grow from $137.7 billion in 2026 to $1.43 trillion by 2034, a CAGR of 34%. — Massive projected long-term market expansion increases the total addressable market and growth potential for established players.
+0.60An administrative hearing on June 29 could potentially extend Schedule III status to adult-use recreational marijuana. — Expanding tax benefits to the recreational segment would further increase margins across a larger portion of the industry's revenue streams.
+0.50Continue reading
6 related stories
Green Thumb Industries reported Q1 revenue of $300.2 million (up 7.4% YoY) and EPS of $0.07 (up 75% YoY). — Strong financial growth and profitability differentiate the company from struggling peers in a volatile sector.
+0.40Green Thumb Industries repurchased $33.3 million of its own shares in the first quarter. — Aggressive buybacks signal management confidence in undervaluation and provide a structural floor for the stock price.
+0.30Ticker attribution
Model heads
The company is described as a 'winner' with strong financials and is poised to benefit significantly from the rescheduling of cannabis to Schedule III.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
7 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Seeking Alpha
1h ago
